Bariatric Surgery for Morbid Obesity-A Cure for Metabolic Syndrome?

Medical Clinics of North America

Volumn 91, Issue 6, 2007, Pages 1255-1271

  Kini, Subhash ^a   Herron, Daniel M ^a   Yanagisawa, Robert T ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INSULIN;

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; DRUG TREATMENT FAILURE; GASTRIC BANDING; GRAFT OCCLUSION; HORMONE RELEASE; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INTESTINE OBSTRUCTION; LAPAROSCOPIC SURGERY; METABOLIC SYNDROME X; MORBID OBESITY; OUTCOME ASSESSMENT; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; STOMACH BYPASS; TREATMENT INDICATION; WEIGHT REDUCTION;

BARIATRIC SURGERY; HUMANS; METABOLIC SYNDROME X; OBESITY, MORBID; TREATMENT OUTCOME;

EID: 35448982718     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2007.06.007     Document Type: Review

References (36)

1. Christou N.V., Sampalis J.S., Liberman M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 (2004) 416-423
2. Gastrointestinal surgery for severe obesity: National Institutes of Health consensus development conference statement. Am J Clin Nutr 55 (1992) 615S-619S
3. Flegal K.M., Graubard B.I., Williamson D.F., et al. Excess deaths associated with underweight, overweight, and obesity. JAMA 293 (2005) 1861-1867
4. Oldridge N.B., Stump T.E., Nothwehr F.K., et al. Prevalence and outcomes of comorbid metabolic and cardiovascular conditions in middle- and older-age adults. J Clin Epidemiol 54 (2001) 928-934
5. Buchwald H., and Williams S.E. Bariatric surgery worldwide 2003. Obes Surg 14 (2004) 1157-1164
6. Balsiger B.M., Poggio J.L., Mai J., et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg 4 (2000) 598-605
7. Lee C.M., Cirangle P.T., and Jossart G.H. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc (2007) epub ahead of print
8. Shikora S.A., and Storch K. Implantable gastric stimulation for the treatment of severe obesity: the American experience. Surg Obes Relat Dis 1 (2005) 334-342
9. Mason E.E., and Ito C. Gastric bypass in obesity. Surg Clin North Am 47 (1967) 1345-1351
10. Higa K.D., Ho T., and Boone K.B. Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A 11 (2001) 377-382
11. Cummings D.E., Weigle D.S., Frayo R.S., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
12. Stenstrom B., Zhao C.M., Tommeras K., et al. Is gastrin partially responsible for body weight reduction after gastric bypass?. Eur Surg Res 38 (2006) 94-101
13. MacLean L.D., Rhode B.M., and Nohr C.W. Late outcome of isolated gastric bypass. Ann Surg 231 (2000) 524-528
14. Wittgrove A.C., Clark G.W., and Schubert K.R. Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3-30 months follow-up. Obes Surg 6 (1996) 500-504
15. Nguyen N.T., Lee S.L., Goldman C., et al. Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass: a randomized trial. J Am Coll Surg 192 (2001) 469-476
16. Fisher B.L., Atkinson J.D., and Cottam D. Incidence of gastroenterostomy stenosis in laparoscopic Roux-en-Y gastric bypass using 21- or 25-mm circular stapler: a randomized prospective blinded study. Surg Obes Relat Dis 3 (2007) 176-179
17. Gumbs A.A., Duffy A.J., and Bell R.L. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis 2 (2006) 460-463
18. Comeau E., Gagner M., Inabnet W.B., et al. Symptomatic internal hernias after laparoscopic bariatric surgery. Surg Endosc 19 (2005) 34-39
19. Higa K.D., Boone K.B., and Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients-what have we learned?. Obes Surg 10 (2000) 509-513
20. Schauer P.R., Ikramuddin S., Gourash W., et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 232 (2000) 515-529
21. Ponce J., Paynter S., and Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 201 (2005) 529-535
22. Bowne W.B., Julliard K., Castro A.E., et al. Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: a prospective, comparative analysis. Arch Surg 141 (2006) 683-689
23. Marceau P., Hould F.S., Simard S., et al. Biliopancreatic diversion with duodenal switch. World J Surg 22 (1998) 947-954
24. Hess D.S., and Hess D.W. Biliopancreatic diversion with a duodenal switch. Obes Surg 8 (1998) 267-282
25. Scopinaro N., Adami G.F., Marinari G.M., et al. Biliopancreatic diversion. World J Surg 22 (1998) 936-946
26. Ren C.J., Patterson E., and Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg 10 (2000) 514-523
27. Aggarwal S., Kini S.U., and Herron D.M. Laparoscopic sleeve gastrectomy for morbid obesity: a review. Surg Obes Relat Dis 3 (2007) 189-194
28. Pratt G.M., McLees B., and Pories W.J. The ASBS bariatric surgery centers of excellence program: a blueprint for quality improvement. Surg Obes Relat Dis 2 (2006) 497-503
29. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 (1995) 339-350
30. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 351 (2004) 2683-2693
31. Polyzogopoulou E.V., Kalfarentzos F., Vagenakis A.G., et al. Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery. Diabetes 52 (2003) 1098-1103
32. Morinigo R., Moize V., Musri M., et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 91 (2006) 1735-1740
33. Laferrere B., Heshka S., Wang K., et al. Incretin levels and effect are markedly enhanced one month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care 30 7 (2007) 1709-1716
34. Farilla L., Bulotta A., Hirshberg B., et al. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144 (2003) 5149-5158
35. le Roux C.W., Aylwin S.J., Batterham R.L., et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg 243 (2006) 108-114
36. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 (2004) 1724-1737